Quantcast
Last updated on April 18, 2014 at 0:14 EDT

Latest Dynavax Technologies Corporation Stories

2013-07-23 08:31:19

Editor Note: For more information about this release, please scroll to bottom. LONDON, July 23, 2013 /PRNewswire/ -- On Monday, July 22, 2013, shares in drug companies ended mostly higher, tracking gains in the broader market which posted small gains. The major movers in the industry included Dynavax Technologies Corporation (NASDAQ: DVAX), Avanir Pharmaceuticals Inc. (NASDAQ: AVNR), Warner Chilcott Plc (NASDAQ: WCRX), and Actavis Inc. (NYSE: ACT). All these companies are...

2013-06-21 20:20:08

NEW YORK, June 21, 2013 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Dynavax Technologies Corporation ("Dynavax" or the "Company") (NASDAQ: DVAX). (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) The investigation focuses on whether Dynavax made materially false and misleading statements regarding the viability of HEPLISAV, the Company's lead product candidate. Specifically, the...

2013-06-19 08:27:58

LONDON, June 19, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Drug manufacturers in the U.S., as well as globally, have been facing increasing competition from generic drug makers following the expiration of patents on several blockbuster drugs. In 2013 alone, patents on drugs with annual sales of nearly $30 billion are set to expire. This will lead to further generic competition. The "patent cliff" has created...

2013-06-11 12:28:42

NEW YORK, June 11, 2013 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Dynavax Technologies Corporation ("Dynavax" or the "Company") (NasdaqCM: DVAX -News). The investigation focuses on whether the Company and its executives violated federal securities laws. On June 10, 2013, shares of Dynavax fell as much as 42% after reporting its findings from a meeting with the Food and Drug Administration...

2013-02-12 08:30:28

LONDON, February 12, 2013 /PRNewswire/ -- Any drug company's stock price hinges on the performance of its drugs. One of the very first steps involved in marketing a drug is getting the approval of FDA. Dynavax Technologies Corporation (NASDAQ: DVAX) is one such company that pointed out that the point recently. The stock plummeted when its drug candidate received poor reviews. However, the same Hepatitis B drug is now waiting for the final approval and the FDA's decision will...

2012-11-21 08:24:52

VANCOUVER, British Columbia, Nov. 21, 2012 /PRNewswire/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and equity research for the following companies: Seagate (NASDAQ:STX), Sprint (NYSE:S), Agilent Technologies (NYSE:A), Valero Energy (NYSE:VLO), Blackstone (NYSE:BX), and Dynavax (NASDAQ:DVAX). (Logo: http://photos.prnewswire.com/prnh/20121105/HK06856LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)...

2012-11-14 08:39:10

VANCOUVER, British Columbia, Nov. 14, 2012 /PRNewswire/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and equity research for the following companies: Dynavax (NASDAQ:DVAX), AK Steel Holding (NYSE:AKS), Halcon Resources (NYSE:HK), Charles Schwab (NYSE:SCHW), NII Holdings (NASDAQ:NIHD), and Xerox (NYSE:XRX). (Logo: http://photos.prnewswire.com/prnh/20121105/HK06856LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full...

2012-02-03 07:55:00

VANCOUVER, British Columbia, Feb. 3, 2012 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: Entropic (NASDAQ:ENTR), Activision Blizzard (NASDAQ:ATVI), and Dynavax Technologies (NASDAQ:DVAX). (Logo: http://photos.prnewswire.com/prnh/20111214/HK22486LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.) Report Highlights: Entropic...

2010-07-12 08:33:00

Findings Could Lead to Lower Doses of Medication for Lupus Patients, Reducing Serious Side Effects DALLAS, July 12 /PRNewswire-USNewswire/ -- Two immune system proteins could be the culprit behind many lupus patients' resistance to widely used steroid treatments, scientists with the Baylor Research Institute (BRI) in Dallas announced today. It is estimated that more than 5 million people suffer from lupus worldwide. Currently, those with lupus and other autoimmune diseases, commonly treat...

2008-11-06 18:00:22

Dynavax Technologies Corporation (NASDAQ:DVAX) announced today that it will present at the Credit Suisse 2008 Healthcare Conference on Wednesday, November 12, 2008 at 3:00 p.m. MST (2:00 p.m. PST) in Phoenix, Arizona. Dino Dina, M.D., President and Chief Executive Officer, will present a corporate overview of Dynavax. The presentation will be webcast. To access the live audio broadcast and the subsequent archived audio recording of the presentation, please log onto the company's website...